Sanofi SNY
NASDAQ SNY
$42.48 -0.66 (-1.53%)
At close: Sep 18, 2026 · 4:00 PM EDT

Sanofi (SNY) Goodwill & Intangibles (2009 - 2026)

Sanofi's (SNY) quarterly Goodwill & Intangibles came in at $79.4 billion in Q2 2026, up 15.54% year-over-year from $68.7 billion in Q2 2025, and down 1.83% quarter-over-quarter from $80.9 billion in Q1 2026.

Analysis

Sanofi (SNY) Goodwill & Intangibles (2009 - 2026) Analysis & Trends

Sanofi has disclosed Goodwill & Intangibles across 18 years of filings, most recently posting $79.4 billion for Q2 2026.

  • In Q2 2026, Goodwill & Intangibles rose 15.54% year-over-year to $79.4 billion; the TTM figure through Jun 2026 stood at $79.4 billion (up 15.54% YoY), while the FY2025 annual figure was $78.6 billion, up 10.07% from the prior year.
  • Goodwill & Intangibles came in at $79.4 billion for Q2 2026 at Sanofi, down from $80.9 billion in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $82.6 billion in Q2 2024 to a low of $67.1 billion in Q1 2025.
  • Average Goodwill & Intangibles over 5 years is $76.5 billion, with a median of $79.0 billion recorded in 2025.
  • Year-over-year, Goodwill & Intangibles fell 16.83% in 2025 and increased 20.5% in 2026.
  • Over 5 years, Goodwill & Intangibles stood at $73.0 billion in 2022, then advanced by 8.69% to $79.3 billion in 2023, then dropped by 11.07% to $70.5 billion in 2024, then climbed by 11.49% to $78.6 billion in 2025, then grew by 0.97% to $79.4 billion in 2026.
  • Per Business Quant data, the three most recent Goodwill & Intangibles figures were $79.4 billion in Q2 2026, $80.9 billion in Q1 2026, and $78.6 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 79.40 Bn
Mar 31, 2026 80.88 Bn
Dec 31, 2025 78.64 Bn
Sep 30, 2025 80.51 Bn
Jun 30, 2025 68.73 Bn
Mar 31, 2025 67.12 Bn
Dec 31, 2024 70.54 Bn
Jun 30, 2024 82.63 Bn
Dec 31, 2023 79.32 Bn
Jun 30, 2023 80.40 Bn
Dec 31, 2022 72.98 Bn
Jun 30, 2022 77.40 Bn
Dec 31, 2021 79.46 Bn
Jun 30, 2021 77.61 Bn
Dec 31, 2020 74.86 Bn
Jun 30, 2020 68.59 Bn
Dec 31, 2019 67.62 Bn
Jun 30, 2019 71.37 Bn
Dec 31, 2018 75.47 Bn
Sep 30, 2018 87.23 Mn